Full transcript of October 2003 National Symposium on Drug Importation

October 23, 2003
Diane Carol Bast

Elected officials, policy analysts, and business leaders came together in Chicago on October 23 for a National Symposium to discuss the pros and cons of prescription drug importation. Video clips of speakers and a video news release are now available online.

What's Wrong with Importing Drugs from Canada?
(complete transcript - PDF - 343 kb)


Video News Release


Speakers (in alpha order)
Joseph L. Bast

President

The Heartland Institute


Introduction (transcript)

The Pros and Cons of Drug Importation (transcript)
Stephen Entin

President

Institute for Research on the Economics of Taxation


The Dubious Economics of Drug Importation

video * transcript
Robert Goldberg

Senior Fellow

Manhattan Institute


Small Gains, Enormous Risks

video * transcript
John Graham
Director of Pharmaceutical Policy Research
Fraser Institute


A Canadian Economist's Perspective

video * transcript
Sean Heather
Executive Director of Congressional Public Affairs
U.S. Chamber of Commerce


It's Really About Spending, Not Safety

video * transcript
Hon. Chris Lauzen
Illinois State Senator


Don't Just Stand There, Do Something!

video * transcript
David Miller
President
Illinois Biotechnology Industry Organization


The Danger of Unknown and Unknowable Costs

video * transcript
Hon. Steven Rauschenberger
Illinois State Senator


Not a Solution to State Budget Problems

video * transcript
Grace-Marie Turner
President
The Galen Institute


Costs, Compulsory Licensing, and Counterfeiting

video * transcript
Appendices


Appendix 1: The $91 Million Mistake

Appendix 2: Letter from the FDA to the State of Illinois

The event, hosted by The Heartland Institute and cosponsored by the Illinois Manufacturers Association, Illinois Retail Merchants Association, and U.S. Chamber of Commerce, was the first open-to-the-public discussion of Illinois Governor Rod Blagojevich's proposal to import Canadian prescription drugs to lower the state’s spending on Medicaid and public employee health benefits.

The following links provide additional information on the topic, including materials distributed at the Symposium.